These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 1871551

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Frequency and pattern of karyotypic abnormalities in human prostate cancer.
    Brothman AR, Peehl DM, Patel AM, McNeal JE.
    Cancer Res; 1990 Jun 15; 50(12):3795-803. PubMed ID: 2340524
    [Abstract] [Full Text] [Related]

  • 4. Chromosomal changes associated with progression of the Dunning R-3327 rat prostatic adenocarcinoma system.
    Wake N, Isaacs J, Sandberg AA.
    Cancer Res; 1982 Oct 15; 42(10):4131-42. PubMed ID: 7105009
    [Abstract] [Full Text] [Related]

  • 5. Cytogenetic and ploidy analysis of prostatic adenocarcinoma.
    Perlman EJ, Epstein JI, Long PP, Pizov G, Griffin CA.
    Mod Pathol; 1993 May 15; 6(3):348-52. PubMed ID: 8346183
    [Abstract] [Full Text] [Related]

  • 6. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M, Bauknecht T, Schmidt J, Walz L, Pfleiderer A.
    Cancer Detect Prev; 1995 May 15; 19(3):234-43. PubMed ID: 7750111
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chromosomal analysis of human prostatic adenocarcinoma cell lines.
    Ohnuki Y, Marnell MM, Babcock MS, Lechner JF, Kaighn ME.
    Cancer Res; 1980 Mar 15; 40(3):524-34. PubMed ID: 7471073
    [Abstract] [Full Text] [Related]

  • 11. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J, Hirasawa K, Bostwick DG, Bergstralh EJ, Slezak JM, Anderl KL, Borell TJ, Lieber MM, Jenkins RB.
    Mod Pathol; 2002 Jan 15; 15(1):35-44. PubMed ID: 11796839
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM, Berger AP, Moore DH, Bartsch G, Klocker H, Carroll PR, Loening SA, Jensen RH.
    Prostate; 2004 Apr 01; 59(1):43-58. PubMed ID: 14991865
    [Abstract] [Full Text] [Related]

  • 18. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
    Bratt O, Anderson H, Bak-Jensen E, Baldetorp B, Lundgren R.
    Urology; 1996 Feb 01; 47(2):218-24. PubMed ID: 8607238
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.